| Primary |
| Hormone Replacement Therapy |
83.9% |
| Hormone Therapy |
4.8% |
| Oestrogen Replacement Therapy |
3.2% |
| Hot Flush |
1.6% |
| Hysterectomy |
1.6% |
| Menopausal Symptoms |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Vulvovaginal Dryness |
1.6% |
|
| Breast Cancer |
44.3% |
| Breast Cancer Metastatic |
20.0% |
| Breast Cancer In Situ |
7.1% |
| Weight Increased |
5.7% |
| Breast Cancer Recurrent |
2.9% |
| Suicidal Ideation |
2.9% |
| Urinary Tract Infection |
2.9% |
| Breast Cancer Female |
1.4% |
| Contralateral Breast Cancer |
1.4% |
| Depression |
1.4% |
| Drug Hypersensitivity |
1.4% |
| Endometrial Neoplasm |
1.4% |
| Necrosis |
1.4% |
| Ovarian Cancer Metastatic |
1.4% |
| Pruritus Generalised |
1.4% |
| Thrombosis |
1.4% |
| Urticaria |
1.4% |
|
| Secondary |
| Hormone Replacement Therapy |
79.3% |
| Menopause |
4.6% |
| Menopausal Symptoms |
4.3% |
| Drug Use For Unknown Indication |
3.0% |
| Product Used For Unknown Indication |
2.3% |
| Oestrogen Replacement Therapy |
1.8% |
| Emotional Distress |
0.6% |
| Crohn's Disease |
0.5% |
| Hypertension |
0.5% |
| Osteoporosis |
0.5% |
| Pain |
0.5% |
| Prophylaxis |
0.5% |
| Arthralgia |
0.3% |
| Bipolar Disorder |
0.3% |
| Delayed Puberty |
0.3% |
| Hypothyroidism |
0.3% |
| Acute Lymphocytic Leukaemia |
0.2% |
| Asthma |
0.2% |
| Bipolar I Disorder |
0.2% |
| Blood Cholesterol Increased |
0.2% |
|
| Breast Cancer |
39.1% |
| Breast Cancer Metastatic |
38.5% |
| Contralateral Breast Cancer |
2.7% |
| Thrombosis |
2.5% |
| Breast Cancer Recurrent |
1.7% |
| Cerebrovascular Accident |
1.7% |
| Breast Cancer Female |
1.4% |
| Fibromyalgia |
1.4% |
| Heart Rate Increased |
1.2% |
| Breast Cancer In Situ |
1.0% |
| Deep Vein Thrombosis |
1.0% |
| Myocardial Infarction |
1.0% |
| Weight Increased |
1.0% |
| Hysterectomy |
0.8% |
| Ovarian Cancer |
0.8% |
| Ovarian Cancer Metastatic |
0.8% |
| Progesterone Receptor Assay Positive |
0.8% |
| Transient Ischaemic Attack |
0.8% |
| Weight Decreased |
0.8% |
| Pulmonary Embolism |
0.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.5% |
| Product Used For Unknown Indication |
20.6% |
| Rheumatoid Arthritis |
8.0% |
| Depression |
5.7% |
| Hypertension |
5.2% |
| Pain |
4.9% |
| Hormone Replacement Therapy |
3.9% |
| Osteoporosis |
2.7% |
| Insomnia |
2.6% |
| Diabetes Mellitus |
2.3% |
| Hypothyroidism |
1.9% |
| Anxiety |
1.7% |
| Psoriasis |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Crohn's Disease |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Restless Legs Syndrome |
1.5% |
| Schizophrenia |
1.5% |
| Hypersensitivity |
1.4% |
| Hepatitis C |
1.3% |
|
| Flushing |
8.5% |
| Vomiting |
8.5% |
| Weight Decreased |
8.5% |
| Weight Increased |
7.3% |
| Pain In Extremity |
6.1% |
| Procedural Complication |
6.1% |
| Depression |
4.9% |
| Respiratory Failure |
4.9% |
| Unevaluable Event |
4.9% |
| Drug Ineffective |
3.7% |
| Drug Level Increased |
3.7% |
| Dyspnoea |
3.7% |
| Immune System Disorder |
3.7% |
| Muscle Spasms |
3.7% |
| Oesophageal Perforation |
3.7% |
| Paraesthesia |
3.7% |
| Psoriasis |
3.7% |
| Rash |
3.7% |
| Rash Pruritic |
3.7% |
| Renal Failure |
3.7% |
|
